A detailed history of Manufacturers Life Insurance Company, The transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 94,910 shares of IBRX stock, worth $426,145. This represents 0.0% of its overall portfolio holdings.

Number of Shares
94,910
Previous 94,367 0.58%
Holding current value
$426,145
Previous $596,000 40.94%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.32 - $6.7 $1,802 - $3,638
543 Added 0.58%
94,910 $352,000
Q2 2024

Aug 14, 2024

BUY
$4.82 - $9.15 $61,397 - $116,552
12,738 Added 15.6%
94,367 $596,000
Q1 2024

May 14, 2024

BUY
$3.23 - $6.17 $69,286 - $132,352
21,451 Added 35.65%
81,629 $438,000
Q4 2023

Feb 13, 2024

BUY
$1.25 - $5.21 $18,165 - $75,711
14,532 Added 31.84%
60,178 $302,000
Q3 2023

Nov 15, 2023

SELL
$1.29 - $3.1 $1,647 - $3,958
-1,277 Reduced 2.72%
45,646 $77,000
Q2 2023

Aug 11, 2023

BUY
$1.53 - $6.41 $10,974 - $45,978
7,173 Added 18.05%
46,923 $130,000
Q1 2023

May 15, 2023

BUY
$1.35 - $4.78 $306 - $1,085
227 Added 0.57%
39,977 $72,000
Q4 2022

Aug 11, 2023

BUY
$4.35 - $6.77 $843 - $1,313
194 Added 0.49%
39,750 $201,000
Q4 2022

Feb 13, 2023

BUY
$4.35 - $6.77 $843 - $1,313
194 Added 0.49%
39,750 $201,000
Q3 2022

Aug 11, 2023

SELL
$3.65 - $6.43 $3,204 - $5,645
-878 Reduced 2.17%
39,556 $196,000
Q3 2022

Nov 03, 2022

SELL
$3.65 - $6.43 $3,204 - $5,645
-878 Reduced 2.17%
39,556 $197,000
Q2 2022

Aug 11, 2023

BUY
$2.68 - $6.14 $12,853 - $29,447
4,796 Added 13.46%
40,434 $150,000
Q2 2022

Aug 15, 2022

BUY
$2.68 - $6.14 $12,853 - $29,447
4,796 Added 13.46%
40,434 $150,000
Q1 2022

Aug 11, 2023

SELL
$5.05 - $7.53 $21,911 - $32,672
-4,339 Reduced 10.85%
35,638 $199,000
Q1 2022

May 20, 2022

SELL
$5.05 - $7.53 $30,224 - $45,067
-5,985 Reduced 14.38%
35,638 $200,000
Q4 2021

Feb 16, 2022

BUY
$5.67 - $10.18 $6,548 - $11,757
1,155 Added 2.85%
41,623 $253,000
Q3 2021

Nov 12, 2021

SELL
$9.17 - $14.24 $19,101 - $29,661
-2,083 Reduced 4.9%
40,468 $394,000
Q2 2021

Aug 12, 2021

BUY
$13.41 - $22.4 $313,458 - $523,599
23,375 Added 121.9%
42,551 $608,000
Q1 2021

May 03, 2021

BUY
$12.83 - $42.25 $246,028 - $810,186
19,176 New
19,176 $455,000

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $1.8B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.